Division of Animal Biochemistry, National Dairy Research Institute, Karnal-132001, Haryana, India.
Microbiol Res. 2012 Oct 12;167(9):544-9. doi: 10.1016/j.micres.2012.01.001. Epub 2012 Jan 23.
The use of pediocins as food additives or drugs requires a simple and rapid method by which large quantities of homogeneous pediocin are produced at industrial level. Two centrifugation steps required during initial stages of purification i.e. separation of cells from fermentation broth and collection of precipitates after ammonium sulphate precipitation are the major bottlenecks for their large scale purification. In the present work, pediocin production by a new a dairy strain, Pediococcus pentosaceous NCDC 273 (identical to pediocin PA-1 at nucleotide sequence level), was found to be optimum at initial pH of 6.0 and 7.0 of basal MRS supplemented with 20 g/l of glucose or lactose at 20 and 24 h, respectively. Immobilization of cells through entrapment in alginate-xanthan gum gel beads with chitosan coating resulted in negligible cell release during fermentation. Thus, the cell free extract was directly collected through decantation, avoiding the need of centrifugation step at this stage. Subsequent ammonium sulphate precipitation at isoelectric point of pediocin PA-1 (8.85), using magnetic stirrer at high speed (approx. 1200 rpm), resulted in forceful deposition of precipitates on the wall of precipitation beaker allowing their collection using a spatula, avoiding centrifugation step at this stage also. Further purification using cation-exchange chromatography resulted in yield of 134.4% with more than 320 fold purification with the specific activity of 19×10⁵ AU/mg. The collection of single peak of pediocin at 41.9min in RP-HPLC, overlapping with standard pediocin PA-1, resulted in yield of 1.15 μg from 20 μl of sample applied. The overlapping of RP-HPLC peak and SDS-PAGE band corresponding to 4.6 kDa, confirmed the purity and identity of pediocin 273 as pediocin PA-1.
作为食品添加剂或药物使用时,需要一种简单快速的方法,以便在工业水平上大量生产同质的肠球菌素。在纯化的初始阶段需要进行两次离心步骤,即从发酵液中分离细胞和在硫酸铵沉淀后收集沉淀,这是大规模纯化的主要瓶颈。在本工作中,发现新的乳制品菌株肠球菌 pentosaceous NCDC 273(在核苷酸序列水平上与肠球菌素 PA-1 相同)的肠球菌素生产在初始 pH 值为 6.0 和 7.0 时最佳,基础 MRS 分别补充 20 g/L 的葡萄糖或乳糖,分别在 20 和 24 h 时达到最佳。通过用壳聚糖包被的藻酸钠-黄原胶凝胶珠固定细胞,在发酵过程中几乎没有细胞释放。因此,通过倾析直接收集无细胞提取物,避免在此阶段需要离心步骤。随后在肠球菌素 PA-1 的等电点(8.85)下用硫酸铵沉淀,在高速(约 1200 rpm)下用磁力搅拌器,导致沉淀强烈沉积在沉淀烧杯壁上,使其能够用刮刀收集,也避免在此阶段需要离心步骤。进一步使用阳离子交换层析进行纯化,得到 134.4%的产率,超过 320 倍的纯化,比活度为 19×10⁵ AU/mg。在反相高效液相色谱(RP-HPLC)中收集到 41.9min 的单个肠球菌素峰,与标准肠球菌素 PA-1 重叠,从 20 μl 进样中得到 1.15 μg 的产量。RP-HPLC 峰和 SDS-PAGE 带(对应于 4.6 kDa)的重叠,证实了 273 号肠球菌素的纯度和身份为肠球菌素 PA-1。